SANTHERA PHARM.HD.SF 0,10/ CH1276028821 /
| - - | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| -EUR | - | 0 Turnover: 0.00 |
-Bid Size: - | -Ask Size: - | 114.57 mill.EUR | - | - |
Assets
|
2019 IFRS in mill. CHF |
2020 IFRS in mill. CHF |
2021 IFRS in mill. CHF |
2022 IFRS in mill. CHF |
2023 IFRS in mill. CHF |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 5.6000 | 1.9000 | 1.3240 | 1.0080 | .5820 | ||||||
| Intangible Assets | 58.5000 | 67.7000 | 64.5960 | 59.2060 | 73.9660 | ||||||
| Long-Term Investments | .7000 | .6000 | .4680 | .4440 | .4240 | ||||||
| Fixed Assets | 65.8000 | 71 | 66.4760 | 60.6610 | 74.9720 | ||||||
| Inventories | 6.9000 | .5000 | .4280 | .1080 | 1.8110 | ||||||
| Accounts Receivable | 8.9000 | 4.5000 | 1.9360 | 1.0910 | 2.1550 | ||||||
| Cash and Cash Equivalents | 31.4000 | 12.4000 | 21.2080 | 1.3530 | 30.3700 | ||||||
| Current Assets | 49.3000 | 17.7000 | 24.6410 | 3.0650 | 34.6570 | ||||||
| Total Assets | 115.1000 | 88.7000 | 91.1170 | 63.7260 | 109.6290 | ||||||
Liabilities
|
2019 IFRS in mill. CHF |
2020 IFRS in mill. CHF |
2021 IFRS in mill. CHF |
2022 IFRS in mill. CHF |
2023 IFRS in mill. CHF |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 9.5000 | 5.7000 | 4.5850 | 7.5830 | 5.6160 | ||||||
| Long-term debt | 56.2000 | 57.9000 | 25.7960 | 21.0800 | 0.0000 | ||||||
| Liabilities to Banks | 56.2000 | 68.6000 | - | - | - | ||||||
| Provisions | 11.4000 | 8.6000 | 9.9020 | 24.9720 | 3.8580 | ||||||
| Liabilities | 93.8000 | 95 | 89.7890 | 107.4120 | 49.1650 | ||||||
| Share Capital | 11.1650 | 19.4300 | - | - | - | ||||||
| Total Equity | 21.2000 | -6.4000 | 1.3280 | -43.6860 | 60.4640 | ||||||
| Minority Interests | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Total liabilities equity | 115.1000 | 88.7000 | - | 63.7260 | 109.6290 | ||||||
Income Statement
|
2019 IFRS in mill. CHF |
2020 IFRS in mill. CHF |
2021 IFRS in mill. CHF |
2022 IFRS in mill. CHF |
2023 IFRS in mill. CHF |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 75.4000 | 15 | -1.5950 | 7.4730 | 103.3760 | ||||||
| Depreciation (total) | .3000 | - | - | - | - | ||||||
| Operating Result | -10.4000 | -53.1000 | -56.8880 | -51.9760 | 68.8060 | ||||||
| Interest Income | - | - | 2.1710 | -18.6400 | -13.9850 | ||||||
| Income Before Taxes | -18.4000 | -67.5000 | - | - | - | ||||||
| Income Taxes | -.6000 | -.2000 | .8090 | .4600 | .0039 | ||||||
| Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Net Income | -19 | -67.7000 | -55.5260 | -71.0760 | 54.7820 | ||||||
Per Share
Cash Flow
|
2019 IFRS in mill. CHF |
2020 IFRS in mill. CHF |
2021 IFRS in mill. CHF |
2022 IFRS in mill. CHF |
2023 IFRS in mill. CHF |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 2.6000 | -43.5000 | -37.3590 | -29.8430 | 47.6230 | ||||||
| Cash Flow from Investing Activities | 2.8000 | 1.6000 | .0690 | -3.9320 | -18.0440 | ||||||
| Cash Flow from Financing | 4.1000 | 23.2000 | 46.0220 | 13.9930 | -.1240 | ||||||
| Decrease / Increase in Cash | 9.4000 | -18.9000 | - | - | - | ||||||
| Employees | 117 | 91 | 43 | 51 | - | ||||||
